MedPage Today4h
FDA OKs First Rapid-Acting Insulin Biosimilar for Diabetes
The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
Healio4h
FDA approves subcutaneous Merilog for glycemic control in diabetes
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
Minnesota Daily4d
Insulin costs capped at $35 per month in Minnesota
Minnesota Attorney General Keith Ellison and pharmaceutical company Novo Nordisk reached a settlement to cap insulin costs at ...
FDA approves first rapid-acting insulin
According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...
Type 1 diabetes: Hybrid closed-loop and open-loop systems therapies compared
People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...
New gene switch activates with simple skin patch and could help treat diabetes
ETH researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch ...
Medscape6d
A Review of 20 Years' Experience With the Novopen Family of Insulin Injection Devices
NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...
Does Medicare Cover Ozempic?
Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
Healthline14h
NSYNC’s Lance Bass Says Managing Type 1.5 Diabetes Is a 'Full-Time Job'
NSYNC’s Lance Bass shares his journey with type 1.5 diabetes, also known as latent autoimmune diabetes in adults (LADA). The ...